SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-286916
Filing Date
2021-09-29
Accepted
2021-09-29 17:26:39
Documents
17
Period of Report
2021-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d222119d8k.htm   iXBRL 8-K 37699
2 EX-5.1 d222119dex51.htm EX-5.1 12699
3 EX-10.1 d222119dex101.htm EX-10.1 223746
4 EX-10.2 d222119dex102.htm EX-10.2 75686
8 GRAPHIC g222119g03y10.jpg GRAPHIC 2442
9 GRAPHIC g222119g61c12.jpg GRAPHIC 2265
  Complete submission text file 0001193125-21-286916.txt   567235

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ubx-20210929.xsd EX-101.SCH 2906
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20210929_lab.xml EX-101.LAB 18122
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20210929_pre.xml EX-101.PRE 11415
10 EXTRACTED XBRL INSTANCE DOCUMENT d222119d8k_htm.xml XML 3363
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 211292817
SIC: 2834 Pharmaceutical Preparations